Other
Swab
Swab is an intervention with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
20%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(2)
Other(3)
Detailed Status
unknown3
Completed2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
unknown360%
completed240%
Recent Activity
0 active trials
Showing 5 of 5
completed
Acquisition of Resistant Enterobacteria During Oral Drug Challenge for Betalactams in Children
NCT04062344
unknownnot_applicable
Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites
NCT04288921
completed
Comparison of Scalp Microbiome of Healthy Women Wearing Hijab and Those Who do Not Wear Hijab
NCT05267119
unknown
Biofilm Formation and Antibiotic Sensitivity Patterns
NCT05181163
unknown
Oral Health, Microbial Burden and COVID-19
NCT04668911
Clinical Trials (5)
Showing 5 of 5 trials
NCT04062344
Acquisition of Resistant Enterobacteria During Oral Drug Challenge for Betalactams in Children
NCT04288921Not Applicable
Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites
NCT05267119
Comparison of Scalp Microbiome of Healthy Women Wearing Hijab and Those Who do Not Wear Hijab
NCT05181163
Biofilm Formation and Antibiotic Sensitivity Patterns
NCT04668911
Oral Health, Microbial Burden and COVID-19
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5